4.1 Review

Drug Burden Index in older adults: theoretical and practical issues

期刊

CLINICAL INTERVENTIONS IN AGING
卷 9, 期 -, 页码 1503-1515

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/CIA.S66660

关键词

Drug Burden Index; anticholinergics; sedative medications; high-risk prescribing; older adults; pharmacological risk assessment tools; deprescribing

向作者/读者索取更多资源

Anticholinergic and sedative medications are commonly used in older adults and are associated with adverse clinical outcomes. The Drug Burden Index was developed to measure the cumulative exposure to these medications in older adults and its impact on physical and cognitive function. This narrative review discusses the research and clinical applications of the Drug Burden Index, and its advantages and limitations, compared with other pharmacologically developed measures of high-risk prescribing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records

Nashwa Masnoon, Sarita Lo, Sarah Hilmer

Summary: The study aims to determine the uptake and implementation of recommendations for deprescribing anticholinergic and sedative medications by the medical team, as well as the outcomes of these recommendations.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Geriatrics & Gerontology

Medication Regimen Complexity and Risk of Bleeding in People Who Initiate Oral Anticoagulants for Atrial Fibrillation: A Population-Based Study

Esa Y. H. Chen, Jiaxi Zhao, Jenni Ilomaki, Janet K. Sluggett, J. Simon Bell, Barbara C. Wimmer, Sarah N. Hilmer, Joseph E. Blais, Ian C. K. Wong, Esther W. Chan

Summary: This study found that in patients with atrial fibrillation initiating oral anticoagulants, a more complex medication regimen was associated with a higher risk of bleeding, especially beyond 90 days of treatment.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Geriatrics & Gerontology

Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing

Gizem Gemikonakli, John Mach, Fan Zhang, Martyn Bullock, Trang Tran, Emad El-Omar, Sarah N. Hilmer

Summary: This study found that aging, chronic polypharmacy, and deprescribing have different effects on the diversity and composition of the gut microbiome. The changes in the microbiome are associated with frailty and function.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Geriatrics & Gerontology

New horizons in managing older cancer survivors: complexities and opportunities

Anna R. A. Mislang, Arduino A. Mangoni, Angela Molga, Swatee Jena, Bogda Koczwara

Summary: Older adults who have survived cancer require special attention due to the complex interactions between cancer-related concerns and age-related conditions. The use of geriatric assessment (GA) has helped oncologists assess older patients' overall health, personalize treatment, and improve survival. However, there is a lack of focus on survivorship research in geriatric oncology. Planning for a healthy survivorship should start at cancer diagnosis, and GA can identify potential survivorship issues and optimize care delivery.

AGE AND AGEING (2023)

Article Rehabilitation

Co-design and evaluation of a multidisciplinary teaching resource on mental health recovery involving people with lived experience

Karen Arblaster, Lynette Mackenzie, Niels Buus, Timothy Chen, Katherine Gill, Lisa Gomez, Deborah Hamilton, Nicola Hancock, Andrea McCloughen, Margaret Nicholson, Yvette Quinn, Jo River, Justin Newton Scanlan, Carl Schneider, Richard Schweizer, Karen Wells

Summary: This study describes the co-design of a teaching resource with people with lived experience of mental distress and recovery. The findings suggest that collaborating with people with lived experience has a significant impact on student recovery capabilities.

AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL (2023)

Article Geriatrics & Gerontology

Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med study

Christopher Etherton-Beer, Amy Page, Vasi Naganathan, Kathleen Potter, Tracy Comans, Sarah N. Hilmer, Andrew J. McLachlan, Richard Lindley, Dee Mangin

Summary: This study investigated the effects of deprescribing multiple medications in older people and found that deprescribing reduced the total number of medicines used per participant. However, the impact of deprescribing on survival and other clinical outcomes remains uncertain due to the failure to meet recruitment targets.

AGE AND AGEING (2023)

Article Geriatrics & Gerontology

Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation

Hui Wen Quek, Christopher Etherton-Beer, Amy Page, Andrew J. McLachlan, Sarita Y. Lo, Vasi Naganathan, Leanne Kearney, Sarah N. Hilmer, Tracy Comans, Derelie Mangin, Richard Lindley, Kathleen Potter

Summary: This study aimed to investigate pharmacist deprescribing recommendations for residents in aged care facilities, the acceptance of these recommendations by doctors, and the actual implementation of the accepted recommendations at 12-month follow-up. The results showed that 77% of deprescribing recommendations were accepted by doctors, and 74% of the accepted recommendations were successfully implemented. The most common reason for deprescribing was medication no longer being needed. Pharmacist-led deprescribing recommendations based on an algorithm-based medication review are acceptable to doctors and can significantly reduce inappropriate medication use in aged care facilities.

ARCHIVES OF GERONTOLOGY AND GERIATRICS (2023)

Article Geriatrics & Gerontology

Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study

Kenji Fujita, Patrick Hooper, Nashwa Masnoon, Sarita Lo, Danijela Gnjidic, Christopher Etherton-Beer, Emily Reeve, Parker Magin, J. Simon Bell, Kenneth Rockwood, Lisa Kouladjian O'Donnell, Mouna Sawan, Melissa Baysari, Sarah N. Hilmer

Summary: This study evaluated the impact of a comprehensive intervention bundle using the Drug Burden Index (DBI) on older inpatients. The results showed that the intervention bundle increased the proportion of older patients who had at least one DBI-contributing medication stopped or dose reduced on discharge, particularly sedative and anticholinergic medications.

DRUGS & AGING (2023)

Article Oncology

Comorbidities and their management in women with breast cancer-an Australian survey of breast cancer survivors

Bogda Koczwara, Rosie Meng, Malcolm Battersby, Arduino A. Mangoni, Danielle Spence, Sharon Lawn

Summary: A national survey was conducted among Australian breast cancer survivors to investigate the burden of chronic conditions and the alignment of their care with the principles of chronic condition management. The survey revealed that comorbidities were common among these survivors, but the management of these conditions, as well as breast cancer, was not well-aligned with chronic condition management principles.

SUPPORTIVE CARE IN CANCER (2023)

Article Medicine, Research & Experimental

The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care

Sibel Saya, Patty Chondros, Anastasia Abela, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Gunn, Timothy F. Chen, Thomas M. Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira Milton, Georgia Ramsay, Zoe Siviour, Jamie Liew, Philip Ly, Matthew Thoenig, Raushaan Seychell, Floriana La Rocca, Luke B. Hesson, Nydia Mejias, Terri Sivertsen, Melanie Anne Galea, Chad Bousman, Jon Emery

Summary: This study aims to evaluate the impact of genomic-guided antidepressant prescribing on clinical efficacy and cost-effectiveness. It will be conducted in primary care settings and will primarily measure changes in depressive symptoms after 12 weeks, along with other secondary outcomes. The results will provide evidence to guide clinical practice.

TRIALS (2023)

Article Medicine, General & Internal

Validation of quality indicators for evaluating geriatric pharmacotherapy services in primary care: a mixed methods study

Noriko Sato, Kenji Fujita, Hiroshi Okada, Kazuki Kushida, Timothy F. Chen

Summary: This study evaluated the measurement properties of 121 validated quality indicators for medication safety in geriatric pharmacotherapy. The findings showed that 53 indicators met the criteria for applicability, improvement potential, acceptability, and implementation issues. These indicators can be used to identify patients who may benefit from medication reviews by clinicians and can be applied at different levels of the healthcare system.

BMJ OPEN (2023)

Article Medicine, General & Internal

Evaluation of Inflammation and Oxidative Stress Markers in Patients with Obstructive Sleep Apnea (OSA)

Maria Carmina Pau, Angelo Zinellu, Arduino A. Mangoni, Panagiotis Paliogiannis, Maria Roberta Lacana, Sara Solveig Fois, Sabrina Mellino, Alessandro G. Fois, Ciriaco Carru, Elisabetta Zinellu, Pietro Pirina

Summary: In this study of 259 OSA patients, specific haematological parameters such as albumin, neutrophil and monocyte counts, and the systemic inflammatory response index were found to be associated with reduced oxygen saturation. These findings suggest that these parameters may serve as promising markers for assessing oxygen saturation in OSA patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Medicine, General & Internal

Association between Red Blood Cell Distribution Width and Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis

Biagio Di Lorenzo, Maria Carmina Pau, Elisabetta Zinellu, Arduino A. A. Mangoni, Panagiotis Paliogiannis, Pietro Pirina, Alessandro G. G. Fois, Ciriaco Carru, Angelo Zinellu

Summary: Although polysomnography is the gold standard method to diagnose OSAS, there is a search for simpler and cheaper biomarkers. This study reviewed the potential diagnostic role of RDW, a routine hematological parameter, in OSAS. The results suggest that RDW could be a promising biomarker for OSAS.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Pharmacology & Pharmacy

Pharmaceutical Care Network Europe definition of quality indicators for pharmaceutical care: a systematic literature review and international consensus development

Kenji Fujita, Kjell H. Halvorsen, Noriko Sato, Janja Jazbar, Pilar Modamio, Isabel Waltering, Isabelle De Wulf, Tommy Westerlund, Timothy F. Chen, Martina Teichert

Summary: Pharmacists’ tasks have shifted from logistics to pharmaceutical care, but there is currently no general definition of quality indicators for pharmaceutical care. To address this, the Pharmaceutical Care Network Europe (PCNE) established a working group in 2020 to develop a definition of quality indicators for pharmaceutical care.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2023)

Editorial Material Biology

Protecting the heart

Joshua M. Inglis, Arduino A. Mangoni

Summary: Blocking protein EPAC1 can potentially halt the progression of chemotherapy-induced heart-related side effects.
暂无数据